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Tuesday, September 20, 2022
As the COVID-19 pandemic continues to evolve, we are seeing other emerging public health threats/emergencies and we continue to address
ongoing/emerging disaster issues, the Center for Disaster Medicine has been and will continue to be a source of reliable information, education and
models for mitigation, preparedness, response, and recovery. As such we have expanded this informational document to address the broader areas
addressed by the center while retaining critical COVID19 information. As the pace of new information and changes occur, we will evaluate the current
once per week to determine if this information should be provided on a more frequent basis

                                                                                                                       
David Markenson, M.D., M.B.A.
Director
Center for Disaster Medicine

COVID-19 Statistics
Total Cases

Total Deaths

Total Vaccine
Doses Admin.

Worldwide

612,626,858

6,528,414

12,237,684,975

United States

95,719,253

1,053,893

608,280,611

New Jersey

2,712,623

34,679

18,111,476

New York

6,067,583

71,524

41,241,407

Connecticut

888,862

11,331

8,077,182

Information as of 9/20/22 at 1300 EDT. Source: https://coronavirus.jhu.edu/map.html

United States COVID-19 Case Map / GIS

Center for Disaster Medicine Updates
Coordinating and overseeing COVID-19 screenings at NYMC campus.
Continue to partner with local organizations such as Westchester Department of Emergency Services and Westchester Medical
Center to ensure ongoing collaboration with all public safety agencies.
Coordinating volunteers to support local public health response to COVID-19.
Conducting research and analysis of current events and COVID-19 response to identify strengths and areas for improvement in
other regions.
Updating and developing new programs to provide enhanced education on public health emergencies including pandemics.
Exploring course development opportunities in infection prevention and control for frontline responders in the hospital and in the
field.
Serving as a source of information for COVID-19 related concerns or questions regarding public health, emergency medical service
(EMS), public safety and healthcare response.
Local networking and pandemic response analysis for New York’s tri-state area, using first-person
experiences to highlight current trends.

                                      

The White House
On September 15, 2022, the White House Monkeypox Response Coordinator, Bob Fenton, Dr.
Fauci, Dr. Walensky, and Dr. Daskalakis provided a press briefing regarding monkeypox response.
https://www.whitehouse.gov/briefing-room/press-briefings/2022/09/15/press-briefing-by-whitehouse-monkeypox-response-team-and-public-health-officials-5/
On September 15, 2022, the Biden Administration released an updated COVID-19 Global
Response and Recovery Framework. The world is in a very different place than when the first U.S.
COVID-19 Global Response and Recovery Framework was released in July 2021. At that time,
tens of thousands of people were dying from COVID-19 globally every week. Vaccine doses were
in short supply globally, especially in low and lower-middle income countries, and oral antiviral
treatments had not yet been approved.
https://www.whitehouse.gov/briefing-room/statements-releases/2022/09/15/statement-by-nscspokesperson-adrienne-watson-on-the-updated-covid-19-global-response-and-recoveryframework/
The official website of the White House will deliver updated information as the country grapples
with converging crises. This will include actions to control the COVID-19 pandemic and monkeypox
and provide economic relief, tackle climate change, and advance racial equity and civil rights, as
well as immediate actions to reform our immigration system and restore America’s standing in the
world. This website will provide all information in one central location.
https://www.whitehouse.gov

COVID-19 Website
On March 30, 2022, Biden Administration Launched COVID.gov, a New One-Stop Shop Website
for Vaccines, Tests, Treatments, Masks, and the Latest COVID-19 Information- a new website was
launched in an effort to consolidate information for consumers.
https://www.whitehouse.gov/briefing-room/statements-releases/2022/03/30/fact-sheet-bidenadministration-launches-covid-gov-a-new-one-stop-shop-website-for-vaccines-tests-treatmentsmasks-and-the-latest-covid-19-information/

Health and Human Services (HHS)
For the latest COVID-19 information from HHS
https://www.hhs.gov/about/news/coronavirus/index.html

National Institutes of Health (NIH)
NIH-funded team develops method to identify future SARS-CoV-2 mutations that could affect rapid
antigen test performance- On September 15, 2022, NIH reported that a research team funded by
the National Institutes of Health has shown that commercially available rapid antigen tests can
detect past and present variants of concern and has identified potential mutations that may impact
test performance in the future. As new variants of the SARS-CoV-2 virus continue to emerge,
concerns have been raised about the performance of rapid antigen tests.
https://www.nih.gov/news-events/news-releases/nih-funded-team-develops-method-identify-futuresars-cov-2-mutations-could-affect-rapid-antigen-test-performance
View the latest COVID-19 information from NIH.
https://www.nih.gov/coronavirus

Centers for Disease Control and Prevention (CDC)        
Monkeypox is a rare disease caused by infection with the monkeypox virus.
Monkeypox virus is part of the same family of viruses as variola virus, the virus that
causes smallpox. Monkeypox symptoms are like smallpox symptoms, but milder, and
monkeypox is rarely fatal. Monkeypox is not related to chickenpox. For the latest
CDC information including symptoms, testing, vaccines and prevention regarding
monkeypox, please visit
https://www.cdc.gov/poxvirus/monkeypox/
According to the CDC, as of September 19, 2022, there are 23,893 cases in the
United States. For the latest monkeypox cases in the United States, please visit:
https://www.cdc.gov/poxvirus/monkeypox/response/2022/us-map.html
According to the CDC, as of September 19, 2022, there are 62,406 cases in the
world. For the latest global monkeypox cases, please visit:
https://www.cdc.gov/poxvirus/monkeypox/response/2022/world-map.html
On September 19, 2022, the CDC released a MMWR which provided a case update
in which the Florida Department of Health (FDOH) was notified of a suspected case
of monkeypox in an infant aged less than 2 months who was admitted to a Florida
hospital with a rash and cellulitis. This case report highlights findings from the related
epidemiologic investigation and describes the public health actions taken. This
activity was reviewed by CDC and was conducted consistent with applicable federal
law and CDC policy. This is the youngest patient with confirmed monkeypox infection
in Florida to date.
https://www.cdc.gov/mmwr/volumes/71/wr/mm7138e3.htm?s_cid=mm7138e3_x
On September 15, 2022, the CDC announced the Monkeypox Vaccine Equity Pilot
Program. Equity-focused vaccine projects present an opportunity to pilot creative
ways to reach populations who are most affected by monkeypox virus, while
contributing to our knowledge of best practices in this current outbreak. Dedicated
efforts may reach populations who face barriers to awareness, education, and
prevention measures like vaccination. Barriers could include differences in language,
location of vaccination sites, vaccine hesitancy, mistrust of government, and lack of
access to on-line scheduling technology. Additionally, affected individuals may avoid
accessing vaccination at events oriented toward specific sexual or gender identities
or sexual activity out of fear of being stigmatized. The Monkeypox Vaccine Equity
Pilot Program was developed to demonstrate new, innovative, and non-traditional
ways to address vaccination disparities within populations who are most affected.
https://www.cdc.gov/poxvirus/monkeypox/health-departments/vaccine-equitypilot.html
As of September 7, 2022, the CDC updated the monkeypox section regarding the
latest information on signs and symptoms, vaccines, prevention, sexual health, cases

and data.
https://www.cdc.gov/poxvirus/monkeypox/index.html
The CDC provides updated information about the variants in the United States- The
emerging variants CDC is closely monitoring have mutations in the virus genome that
alter the characteristics and cause the virus to act differently in ways that are
significant to public health (e.g., causes more severe disease, spreads more easily
between humans, requires different treatments, changes the effectiveness of current
vaccines). It’s important to understand that genetic mutations are expected, and
some variants can spread and become predominant while others subside.
https://www.cdc.gov/coronavirus/2019-ncov/transmission/variant-cases.html
The CDC provides daily data tracker which has maps and charts tracking cases,
deaths, and
trends of COVID-19 in the United States- updated daily by 8 pm ET.
https://covid.cdc.gov/covid-data-tracker/#datatracker-home
For the latest CDC information
https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/index.html

United States Food and Drug Administration (FDA)

As of September 16, 2022, 438 tests and sample collection devices are authorized by
the FDA under emergency use authorizations (EUAs). These include 301 molecular
tests and sample collection devices, 85 antibody and other immune response tests,
51 antigen tests, and 1 diagnostic breath test. There are 79 molecular authorizations
and 1 antibody authorization that can be used with home-collected samples. There is
1 EUA for a molecular prescription at-home test, 2 EUAs for antigen prescription athome tests, 19 EUAs for antigen over-the-counter (OTC) at-home tests, and 3 for
molecular OTC at-home tests. The FDA has authorized 31 antigen tests and 8
molecular tests for serial screening programs. The FDA has also authorized 1114
revisions to EUA authorizations.
https://www.fda.gov/news-events/press-announcements/fda-roundup-september-162022
The FDA created a specific monkeypox response page which serves as a central
source of information regarding diagnostics, vaccines, and therapeutics. For the latest
FDA information regarding monkeypox, please visit
https://www.fda.gov/emergency-preparedness-and-response/mcm-issues/fdamonkeypox-response
For the latest overall FDA information about COVID-19.
https://www.fda.gov/emergency-preparedness-and-response/counterterrorism-andemerging-threats/coronavirus-disease-2019-covid-19

Center for Medicare and Medicaid Services (CMS)
View the latest information from CMS
https://www.cms.gov/About-CMS/Agency-Information/Emergency/EPRO/CurrentEmergencies/Current-Emergencies-page

Vaccines
In this section, vaccine-related information from various sources will be collected,
reviewed, and tabulated here. As of July 19, 2022, the FDA has granted Emergency
Use Authorization (EUA) to Janssen/Johnson & Johnson for adults over 18 years and
Novavax for adults over 18 years of age and EUA for Moderna and Pfizer for children
6 months to five years. On August 26, 2022, the FDA authorized the emergency use
of Novavax COVID-19 Vaccine, Adjuvanted for the prevention of Coronavirus
Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) in individuals 12 through 17 years of age. This authorization follows
a rigorous analysis and evaluation of the safety and effectiveness data conducted by
the FDA. On August 23, 2021, the FDA granted full approval to Pfizer for adults. On
January 31, 2022, the FDA granted full approval to Moderna for adults. Now with two
vaccines with full FDA approval and three vaccines with EUA for adults and children,
the goal is to vaccinate a larger number of persons in the coming months throughout
the United States. As additional vaccines are granted EUA, information for those
vaccines will also be included.
CDC created this section regarding COVID-19 vaccinations in the United StatesCDC provides overall US COVID-19 Vaccine, deliveries and administration, maps,
charts, and data updated daily by 8 PM. This section represents all vaccine partners
including jurisdictional partner clinics, retail pharmacies, long-term care facilities,
Federal Emergency Management Agency and Health Resources and Services
Administration partner sites, and federal entity facilities.
https://covid.cdc.gov/covid-data-tracker/#vaccinations_vacc-total-admin-rate-total
The NYS DOH COVID-19 Vaccine Tracker Dashboard will update New Yorkers on
the distribution of the vaccine including the number of doses received by the state, a
breakdown of first or second doses, and the number of persons vaccinated with the
first and second doses in each region.
https://covid19vaccine.health.ny.gov/covid-19-vaccine-tracker

The NYS DOH provides updated monkeypox information regarding signs and
symptoms, cases, vaccine, treatment and prevention at
https://health.ny.gov/diseases/communicable/zoonoses/monkeypox/
CDC created this section regarding the Johnson & Johnson’s Janssen vaccine to
provide updated relevant information including side effects and safety data, clinical
trials demographic statistics, and information on how the vaccine works.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/janssen.html
CDC created this section regarding the Moderna vaccine to provide updated relevant
information including side effects and safety data, clinical trials demographic
statistics, and information on how the vaccine works. As of January 31, 2022, the fully
FDA approved Moderna vaccine will now be known as SPIKEVAX for ages 6 months
and older.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/differentvaccines/Moderna.html
CDC created this section regarding the Pfizer BioNTech vaccine to provide updated
relevant information including side effects and safety data, clinical trials demographic
statistics, and information on how the vaccine works. As of October 16, 2021, the fully
FDA approved Pfizer vaccine will now be known as COMIRNATY for ages 6 months
and older.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/PfizerBioNTech.html
HHS created this section to provide the latest information about COVID-19 vaccines.
https://www.hhs.gov/coronavirus/covid-19-vaccines/index.html
For NYC DOHMH updated guidance regarding COVID-19 vaccine
https://www1.nyc.gov/site/doh/covid/covid-19-vaccines.page
The Vaccine Finder is a one-stop site for New Yorkers to find their nearest COVID-19
vaccination location. The Vaccine Finder can also provide New Yorkers with
information to schedule vaccination appointments.
https://vaccinefinder.nyc.gov/

Educational Institution Information
Higher Education
Many surveys of student attitudes about online learning during the
pandemic focus on the majority of learners who found themselves
studying online against their will. The closing of their campuses thrust
them into virtual courses that neither they (nor, in many cases, their
instructors) were prepared for. As a result, many such surveys
found mixed reviews of online learning. Many thousands of students
actively choose virtual programs, however, because their work or family
lives demand it, and a new survey finds that such students are more
satisfied with their online programs than they were before the
pandemic. The report, published by Wiley University Services, is based
on a national survey of 2,500 adults who are enrolled in, planning to
enroll in or recently graduated from fully online degree or certificate
programs. A strong majority (94 percent) of respondents rated their
online college experiences as “positive” or “very positive,” compared
with 86 percent before the pandemic. Most of these learners choosing
to study fully online are driven to study by career goals. These students
are cost conscious but hesitate to use employer-sponsored tuition
benefits. They strongly prefer asynchronous learning but are willing to
join occasional synchronous or on-campus sessions. The population
seeking online colleges more than 100 miles away is shrinking. And
nearly half of online graduates are willing to return to the same
institution for another degree.
K-12
Head Start programs are expressing relief after the U.S. Department of
Health and Human Services notified them late Friday of plans to drop
the universal masking requirement for children, teachers and staff. The
requirement had remained in effect despite changes to COVID-19
guidance from the Centers for Disease Control and Prevention. In
recent weeks, many lawmakers and Head Start programs have called
on the federal agency to drop universal masking. While HHS has not
yet issued a final rule formally changing the requirement, it said in an
email it will do so for individuals 2 and older in the near future. In the
meantime, the Office of Head Start will not monitor mask use and has
in fact not done so since February 2022, when the updated guidance
from the CDC was released, the email said. The announcement
restores local authority to the programs, said Tommy Sheridan, deputy

director of the National Head Start Association, in a statement on
Friday. He added that he is “grateful for today’s announcement that
finally gives us the clarity we have been
seeking.”  https://www.k12dive.com/news/health-and-human-servicesdrops-mask-requirement-for-head-start-programs/632151/

Clinical Trials
To view the latest information on clinical trials regarding COVID-19
https://www.clinicaltrials.gov/ct2/results?
recrs=&cond=Covid19&term=&cntry=&state=&city=&dist=

American Red Cross
https://www.redcrossblood.org/donate-blood/dlp/plasma-donations-from-recoveredcovid-19-patients.html

State Updates

New York
Governor Kathy Hochul announced that the applications portal for the first-in-the-nation Seed Funding Grant
Program, created as part of the FY2023 budget, will open on September 14. The program provides flexible grants
to support early stage, micro and small businesses in a still recovering New York State economy. The program will
ensure that small businesses that opened shortly before or during the COVID-19 pandemic will have the funds to
continue to operate and grow. "This first-in-the-nation Seed Funding Grant Program rounds out $1 billion in flexible
funding to support both early-stage, and established small and micro-businesses," Governor Hochul said. "New
York businesses were among the hardest hit nationwide at the height of the pandemic, but with this funding, we're
extending a lifeline to help them continue to grow and operate. Applications open tomorrow, and I encourage all
New York business owners to take full advantage and be a part of New York's remarkable recovery." This program
builds upon New York State's existing $800 million Pandemic Small Business Recovery Grant Program, which has
delivered more than $639 million to over 35,000 small businesses since it launched last year, with ninety percent of
funding having gone to minority and women-owned businesses. Starting today, Empire State Development will
expand eligibility for the program, enabling more small businesses to access funding by removing the requirement
that businesses show a twenty-five percent loss in annual gross receipts from 2019 to 2020. This expansion of
eligibility comes in addition to previous program changes to profitability requirements and revenue thresholds,
aimed at serving additional small businesses. The program, which will continue to process applications currently in
the pipeline, will close as funding winds down on September 30,
2022. https://www.governor.ny.gov/news/governor-hochul-announces-launch-new-yorks-first-nation-200-millionseed-funding-grant-early

New York State Department of Health (DOH)
On September 19, 2022, Governor Hochul updated New Yorkers on the state's progress combating COVID-19. "As we
continue to navigate the start of the fall season, I urge all New Yorkers to take steps to better protect themselves against
COVID-19," Governor Hochul said. "Take advantage of the latest tools and resources at our disposal in order to keep our
families and our communities safe. Test before gatherings or travel and if you test positive, talk to your doctor about
potential treatment options."
https://www.governor.ny.gov/news/governor-hochul-updates-new-yorkers-states-progress-combating-covid-19-345
On September 13, 2022, Governor Hochul announced that the applications portal for the first-in-the-nation Seed Funding
Grant Program, created as part of the FY2023 budget, will open on September 14. The program provides flexible grants to
support early stage, micro and small businesses in a still recovering New York State economy. The program will ensure
that small businesses that opened shortly before or during the COVID-19 pandemic will have the funds to continue to
operate and grow. "This first-in-the-nation Seed Funding Grant Program rounds out $1 billion in flexible funding to support
both early-stage, and established small and micro-businesses," Governor Hochul said. "New York businesses were
among the hardest hit nationwide at the height of the pandemic, but with this funding, we're extending a lifeline to help
them continue to grow and operate. Applications open tomorrow, and I encourage all New York business owners to take
full advantage and be a part of New York's remarkable recovery."
https://www.governor.ny.gov/news/governor-hochul-announces-launch-new-yorks-first-nation-200-million-seed-fundinggrant-early
For a list of COVID-19 positive cases by county in New York Statehttps://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19Tracker-Map?
%3Aembed=yes&%3Atoolbar=no&%3Atabs=n
The NYS DOH has created a dynamic COVID-19 Tracker which provides COVID-19 information regarding testing, cases,
percentages, and fatalities across New York State. It also breaks down cases by county.
https://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19Tracker-Map?
%3Aembed=yes&%3Atoolbar=no&%3Atabs=n

For the latest COVID-19 information from the NYS DOH
https://coronavirus.health.ny.gov/home
As of September 19, 2022, there are 3,702 cases of monkeypox in New York State. For the latest monkeypox information
including vaccines and provider information from the NYS DOH, please visit:
https://www.health.ny.gov/diseases/communicable/zoonoses/monkeypox/

Connecticut
Governor Ned Lamont announced that his administration is releasing $150 million toward a newly established state grant program dedicated to
supporting upgrades for heating, ventilation, and air conditioning (HVAC) systems in Connecticut public schools. The grants will supplement more
than $165 million that schools have already committed for air filtration improvements since the start of the COVID-19 pandemic through funding they
received from the federal Elementary and Secondary School Emergency Relief (ESSER) Fund. The governor said that he is creating the state grant
program to ensure that schools have a dedicated source of funding to support additional infrastructure upgrades, noting that the pandemic exposed a
significant need to have modernized air filtration units in schools. “One thing the COVID-19 pandemic showed is that many school buildings in our
state, particularly those that are of a certain age, are in serious need of air quality improvements,” Governor Lamont said. “Modernized ventilation
systems provide an important public health function that filtrate the air and reduce airborne contaminants, including particles containing viruses. Most
importantly, these air filtration systems will help ensure that our students can continue receiving their education in-person, in the classroom, where
they learn best. Over the last two years, school districts in Connecticut have invested more than $165 million in COVID-relief funding to make these
kinds of air quality improvements, and by creating a state program dedicated to these upgrades, we can continue providing schools with additional
funding to implement these much-needed infrastructure enhancements.” https://portal.ct.gov/Office-of-the-Governor/News/Press-Releases/2022/092022/Governor-Lamont-Announces-150-Million-To-Make-Additional-Air-Filtration-System-Upgrades

Local Updates
New York Blood Center (NYBC)
For the latest updated NYBC information about COVID-19:
https://nybc.org/covid-19/

New York City (NYC) Department of Health and Mental Hygiene (DOHMH)
New York City is currently the epicenter of the monkeypox outbreak in the United States. As of September 19, 2022, there are 3.402 cases of
monkeypox in New York City. For the latest information including cases, symptoms, testing and vaccine information regarding monkeypox in New York
City, please visit
https://www1.nyc.gov/site/doh/health/health-topics/monkeypox.page
NYC DOHMH launched a new COVID-19 variants data page. The data on this page show how variants of the virus that causes COVID-19 are
spreading in NYC. Variants are versions of the virus with certain sets of mutations. Some variants may result in a COVID-19 infection that is easier to
spread, more severe or able to avoid antibodies from vaccines or previous infections.
https://www1.nyc.gov/site/doh/covid/covid-19-data-variants.page
For NYC DOHMH updated COVID-19 data page
https://www1.nyc.gov/site/doh/covid/covid-19-data.page

Westchester County Department of Health
For the latest breakdown of COVID-19 positive cases in Westchester County as of September 19, 2022
https://wcgis.maps.arcgis.com/apps/dashboards/280339d96db14efd9cc304dba0f3a71d
For the latest COVID-19 information in Westchester including vaccines for children.

https://health.westchestergov.com/2019-novel-coronavirus
As of September 19, 2022, Westchester County has 85 cases of monkeypox.
Monkeypox Vaccine Clinics on Mondays and Wednesdays at 134 Court Street, White Plains. Appointments are required. People at higher risk for
monkeypox infection may consider vaccination with the two-dose JYNNEOS vaccine. In accordance with CDC guidance, this includes those who:
Had contact with someone who had a rash that looks like monkeypox or with someone who was diagnosed with confirmed or probable
monkeypox
Had skin-to-skin contact with someone in a social network experiencing monkeypox activity; this includes men who have sex with men who
meet partners through an online website, digital application (“app”), or social event such as at a bar or party  
Traveled outside the United States to a country with confirmed cases of monkeypox or where monkeypox activity has been ongoing
Monkeypox Vaccine appointments are also available at:
- Westchester Medical Center, 15 Oval Connector, Valhalla, NY 10595
Monday through Friday from 9 am - 5 pm, appointment required.
Call (914) 326-2060 to schedule an appointment.
For more information regarding monkeypox in Westchester County, please visit
https://health.westchestergov.com/

Putnam County Department of Health
Breakdown of COVID -19 positive cases by towns in Putnam County as of September 16, 2022.
https://www.putnamcountyny.com/covid19/
As of September 19, 2022, there are 4 cases of monkeypox in Putnam County.
For the latest COVID-19 information
https://www.putnamcountyny.com/health/coronavirus/

Dutchess County Department of Health
Breakdown of positive cases in Dutchess County as of September 16, 2022.
https://www.dutchessny.gov/Departments/DBCH/covid-19-dashboard.htm
For the latest COVID-19 information:
https://www.dutchessny.gov/Departments/DBCH/2019-Novel-Coronavirus.htm
As of September 19, 2022, there are 10 cases of monkeypox in Dutchess County. For the latest information regarding monkeypox, please visit
https://www.dutchessny.gov/Departments/DBCH/dbch.htm

Orange County Department of Health
Updated COVID-19 dashboard for Orange County, NY as of September 15, 2022.
https://ocnygis.maps.arcgis.com/apps/dashboards/21de1fb5ce0c480f95dc0cf2b8b83b71
For the latest COVID-19 information
https://www.orangecountygov.com/1906/2019-Novel-Coronavirus-Information
As of September 19, 2022, there are 12 cases of monkeypox in Orange County. For more information regarding monkeypox, please visit
https://www.orangecountygov.com/149/Health

Rockland County Department of Health
Review Rockland County’s dashboard with the latest COVID-19 information regarding cases as of September 19, 2022.
https://www.arcgis.com/apps/dashboards/d074e0336e81449393a76d1768ceb096
For the latest COVID-19 information
https://rocklandgov.com/departments/health/coronavirus-covid-19/
As of September 19, 2022, there is 12 cases of monkeypox in Rockland County.
For more information regarding monkeypox, please visit Rockland County Health Department website
https://rocklandgov.com/departments/health/

Healthcare
For the latest COVID-19 information for healthcare facilities from the Greater New York Hospital Association that covers hospitals in the tri-state area.
https://www.gnyha.org/

   
                                   Center for Disaster Medicine Media

NYMC Leadership News:
How Did Monkeypox Actually Start? Doctors Explain Its History
Parade
9/9/2022
https://parade.com/health/how-did-monkeypox-start
Robert W. Amler, M.D., M.B.A., dean of the School of Health Sciences and Practice and vice president of government affairs

Every effort is made to provide accurate and complete information in this newsletter. However, New York Medical College cannot guarantee that
there will be no errors. NYMC makes no claims, promises or guarantees about the accuracy, completeness, or adequacy of the contents of the
newsletters or the articles linked herein and further expressly disclaims liability for errors and omissions in the contents of this newsletter.
This newsletter is for informational purposes only; it does not constitute medical advice. Always seek the advice of your physician or other qualified
health provider with any questions you may have regarding a medical condition.
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